The Prophet Trial -Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients With Pulmonary Hypertension
Clinical trial NCT03022851 · COMPLETED
Trial details
- NCT number
- NCT03022851
- Sponsor
- Occlutech International AB
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-19
- Primary completion
- 2024-01-08
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.